2 New IPOs Scheduled for the Week of April 28

Francis Gaskins  |

Complete calendar at IPOpremium.com

(1) Based in Los Angeles, CA, Ares Management, LP ($ARES) scheduled a $400 million IPO on the NYSE with a market capitalization of $1.8 billion at a price range midpoint of $22 for Friday, May 2, 2014.

ARES is a leading global alternative asset manager with approximately $74 billion of assets under management and approximately 700 employees in over 15 offices in the United States, Europe and Asia.

(2) Based in Vancouver, WA, Papa Murphys Holdings ($FRSH) scheduled a $70 million IPO on the Nasdaq with a market capitalization of $204 million at a price range midpoint of $12 for Friday, May 2, 2014.

FRSH is a pizza chain that also allows customers to take pizzas home for baking. FRSH has positive operating earnings from its franchise operations but has operating losses from its company-owned stores.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
FRSH Papa Murphy's Holdings Inc. 4.79 0.09 1.91 8,061 Trade
IRBS Ir Biosciences Hldgs Inc 0.00 0.00 0.00 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…